Anish Suri

Company: Cue Biopharma

Job title: President and Chief Scientific Officer

Seminars:

Immuno-STATs: a Novel Class of T Cell Engagers for B Cell Depletion in Autoimmune Diseases 12:00 pm

Immuno-STATs are a new class of TCR-selective engagers for selective modulation of disease-relevant T cells CUE-100 series Immuno-STATs have been clinically validated in oncology, and have demonstrated significant increase in efficacy (ORR and mPFS) vs SoC Here we describe the CUE-500 series, which can re-direct the protective virus-specific T cells (VSTs) to deplete B cells,…Read more

day: Day Two